Caribou Biosciences

Yahoo Finance • last month

August 2025's Top Penny Stocks With Growth Potential

As the U.S. stock market inches higher, with major indices nearing record highs, investors are closely watching key developments such as Nvidia's earnings report and shifts in Federal Reserve policy. Amid these broader market dynamics, pen... Full story

Yahoo Finance • last month

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

BERKELEY, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief e... Full story

Yahoo Finance • 2 months ago

Caribou Biosciences Inc (NASDAQ:CRBU) Posts Mixed Q2 2025 Earnings with Revenue Beat but Wider Loss

CARIBOU BIOSCIENCES INC (NASDAQ:CRBU [https://www.chartmill.com/stock/quote/CRBU]) REPORTS Q2 2025 EARNINGS: MIXED RESULTS AND MARKET REACTION Caribou Biosciences Inc (NASDAQ:CRBU [https://www.chartmill.com/stock/quote/CRBU]) released its... Full story

Yahoo Finance • 3 months ago

CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Caribou (CRBU) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Caribou between July 14, 2023... Full story

Yahoo Finance • 4 months ago

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

BERKELEY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief ex... Full story

Yahoo Finance • 7 months ago

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

-- CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 -- -- Advancing four clinical programs for hematologic malignancies and autoimmune diseases -- -- $249.4 million in cash, cash equivalents,... Full story

Yahoo Finance • 7 months ago

Caribou Biosciences, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; February 24, 2025 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Caribou Biosciences, Inc. ("Caribou " or the "Company") (NASDAQ: CRBU)... Full story

Yahoo Finance • 7 months ago

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc. (CRBU) Shareholders

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou Biosciences, Inc." or the "Company") (NASDAQ: CRBU) of a class action securities lawsuit. CLASS DEFINITION: The... Full story

Yahoo Finance • 8 months ago

CRBU DEADLINE NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 24 Deadline in Securities Class Action – CRBU

NEW YORK, Feb. 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusi... Full story

Yahoo Finance • 8 months ago

Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou Biosciences, Inc." or the "Company") (NASDAQ: CRBU) of a class action securities lawsuit. CLASS DEFINITION: The... Full story

Yahoo Finance • 8 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU

NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU). Shareholders who purchased shares of CRBU during the class period listed are encoura... Full story

Yahoo Finance • 8 months ago

CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Caribou Biosciences, Inc. (“C... Full story

Yahoo Finance • 8 months ago

CRBU DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBU

NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusi... Full story

Yahoo Finance • 8 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Caribou To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Cari... Full story

Yahoo Finance • 8 months ago

Caribou Biosciences to Participate in Upcoming Investor Conferences

BERKELEY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief e... Full story

Yahoo Finance • 8 months ago

Caribou Biosciences, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 24, 2025 to Discuss Your Rights – CRBU

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou Biosciences, Inc." or the "Company") (NASDAQ: CRBU) of a class action securities lawsuit. CLASS DEFINITION: The... Full story

Yahoo Finance • 8 months ago

CRBU IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBU

NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusi... Full story

Yahoo Finance • 8 months ago

Caribou Biosciences, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 24, 2025 Deadline to file Lead Plaintiff Motion.

LOS ANGELES, Feb. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Caribou Biosciences, Inc. ("Caribou " or the "Company") (NASDAQ: CRBU) investors of a class action representing investors that bought securities between July 14,... Full story

Yahoo Finance • 8 months ago

CRBU DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBU

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusi... Full story

Yahoo Finance • 8 months ago

Class Action Filed Against Caribou Biosciences, Inc. (CRBU) - February 24, 2025 Deadline to Join – Contact The Gross Law Firm

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU). Shareholders who purchased shares of CRBU during the class period listed are encoura... Full story